I found this amusing from another board as our fri
Post# of 154722
(Total Views: 532)
Posted On: 08/03/2021 5:12:07 PM
I found this amusing from another board as our friend Adam F. has been quite busy. We are not the only company being tormented by his constant BS.
Cassava's CEO held an unexpected press conference and earnings report this morning in response to the recent "bashing" of the company.
Said Simufilam could be the biggest blockbuster in the history of pharmaceuticals.
Expects a major announcement in the next few weeks or months, hinting at partnership.
Anticipates no need for financing/dilution in the future.
Revenue guidance: "We expect hyper-growth in the next few quarters and couple of years."
Described last week's action on Wall St. as a coordinated, planned attack on the share price.
Referred to Adam F's article as shameful bashing. Said one of the experts quoted has been revealed to be on Biogen's payroll.
Countered that the scientific community as a whole is not questioning the integrity of SAVA's research and trials and is paying close attention.
Referred to Adam F. as misogynistic for questioning the choice of "employee Lindsay"-- not "Dr. Burns"-- as SAVA presenter at the conference, then mentioning that she happens to be married to the CEO. When in fact Dr. Burns has degrees from Harvard and Cambridge, a PhD and has been the lead scientist at Cassava for 10 years.
Cassava's CEO held an unexpected press conference and earnings report this morning in response to the recent "bashing" of the company.
Said Simufilam could be the biggest blockbuster in the history of pharmaceuticals.
Expects a major announcement in the next few weeks or months, hinting at partnership.
Anticipates no need for financing/dilution in the future.
Revenue guidance: "We expect hyper-growth in the next few quarters and couple of years."
Described last week's action on Wall St. as a coordinated, planned attack on the share price.
Referred to Adam F's article as shameful bashing. Said one of the experts quoted has been revealed to be on Biogen's payroll.
Countered that the scientific community as a whole is not questioning the integrity of SAVA's research and trials and is paying close attention.
Referred to Adam F. as misogynistic for questioning the choice of "employee Lindsay"-- not "Dr. Burns"-- as SAVA presenter at the conference, then mentioning that she happens to be married to the CEO. When in fact Dr. Burns has degrees from Harvard and Cambridge, a PhD and has been the lead scientist at Cassava for 10 years.
(9)
(0)